|
186 Products |
| 186 Products |
|
1696 Diseases |  |
94663 News |  |
| «12...1052105310541055105610571058105910601061106210631064 |
- | dexamethasone / Generic mfg., lenalidomide / Generic mfg.
New P2 trial: Randomized Trial Comparing Lenalidomide With Low Dose Dexamethasone Versus Lenalidomide in Second Line Multiple Myeloma (clinicaltrials.gov) - Sep 6, 2011
P2, N=60, Enrolling by invitation, Sponsor: Karolinska University Hospital
- H.P. Acthar Gel (repository corticotropin injection) / Mallinckrodt
Clinical: Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone (clinicaltrials.gov) - Sep 5, 2011
P2/3, N=30, Terminated, Sponsor: Neurologique Foundation, Inc.
Recruiting --> Terminated; Study reached halfway point in approximately one year time period and was halted to analyze data.
- H.P. Acthar Gel (repository corticotropin injection) / Mallinckrodt
Clinical: Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone (clinicaltrials.gov) - Sep 5, 2011
P2/3, N=30, Terminated, Sponsor: Neurologique Foundation, Inc.
Recruiting --> Terminated; Study reached halfway point in approximately one year time period and was halted to analyze data. N=63 --> 30
- |||||||||| betamethasone / Generic mfg., gentamicin sulfate / Generic mfg.
New P3 trial: Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous (clinicaltrials.gov) - Sep 5, 2011
P3, N=76, Completed, Sponsor: EMS
- | triamcinolone acetonide topical / Generic mfg.
New P4 trial: DIPSO: Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis (clinicaltrials.gov) - Sep 5, 2011
P4, N=88, Recruiting, Sponsor: University of Zurich
- | glatiramer acetate / Generic mfg.
Trial completion: Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA) (clinicaltrials.gov) - Sep 5, 2011
P=N/A, N=12, Completed, Sponsor: University at Buffalo
N=63 --> 30 Recruiting --> Completed
- New P2 trial, Combination therapy: An Open-Label Phase II Study of the Safety and Efficacy of Doxorubicin and Cyclophosphamide in Combination with Bortezomib, Lenalidomide, and Dexamethasone for Treatment of Patients with Newly Diagnosed Multiple Myeloma (EUDRACT) - Sep 4, 2011
P2, N=30, Ongoing, Sponsor: Vejle Hospital
- budesonide inhalation suspension / Generic mfg.
Trial withdrawal: Budesonide: Pulmicort Respules on Relapse Rates After Treatment in the ED (clinicaltrials.gov) - Sep 1, 2011
P4, N=0, Withdrawn, Sponsor: Phoenix Children's Hospital
Recruiting --> Completed Terminated --> Withdrawn
- ||| afuresertib (LAE002) / Laekna Therap
New P1 trial, Combination therapy: Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma (clinicaltrials.gov) - Sep 1, 2011
P1, N=90, Recruiting, Sponsor: GlaxoSmithKline
- betamethasone / Generic mfg.
Trial withdrawal: CCAM Steroids: Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM) (clinicaltrials.gov) - Aug 31, 2011
P1/2, N=74, Withdrawn, Sponsor: University of California, San Francisco
Terminated --> Withdrawn Recruiting --> Withdrawn
- mometasone furoate / Generic mfg.
New P2 trial, Head-to-Head: Determination of the anti-psoriatic efficacy of MomeGalen Creme (mometasone furoate 0.1 %) compared to the reference drug Ecural® Fettcreme and to placebo by defined psoriasis parameters Untersuchung der anti-psoriatrischen Wirksamkeit von MomeGalen Creme (mometasone furoate 0.1 %) im Vergleich zu dem Referenzprodukt Ecural® Fettcreme und dem Placebo mittels definierter Parameter für Psoriasis (EUDRACT) - Aug 31, 2011
P2, N=30, Completed, Sponsor: GALENpharma
- | dexamethasone injection / Generic mfg.
Trial completion: Dexamethasone Versus Placebo in Optimizing the Postoperative Period After Laparoscopic Inguinal Hernia Repair (clinicaltrials.gov) - Aug 31, 2011
P3, N=80, Completed, Sponsor: Mette Astrup Madsen
Recruiting --> Withdrawn Recruiting --> Completed
- |||| lenalidomide / Generic mfg., cyclophosphamide / Generic mfg.
Trial completion: Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma (clinicaltrials.gov) - Aug 29, 2011
P2, N=53, Completed, Sponsor: Mayo Clinic
Recruiting --> Completed Active, not recruiting --> Completed
- dexamethasone / Generic mfg., carfilzomib / Generic mfg.
Clinical: Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies (clinicaltrials.gov) - Aug 29, 2011
P1, N=48, Completed, Sponsor: Onyx Pharmaceuticals
Active, not recruiting --> Completed N=86 --> 48
- | dexamethasone / Generic mfg., carfilzomib / Generic mfg.
Clinical: Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies (clinicaltrials.gov) - Aug 29, 2011
P1, N=48, Completed, Sponsor: Onyx Pharmaceuticals
N=86 --> 48 Active, not recruiting --> Completed
- budesonide/formoterol / Generic mfg.
Enrollment open: Study of Preventive Treatment With Symbicort or Budicort Turbohaler in Childhood Asthma Return to School Epidemic (clinicaltrials.gov) - Aug 28, 2011
P=N/A, N=225, Recruiting, Sponsor: Meir Medical Center
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- cisplatin / Generic mfg.
Enrollment open: Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment (clinicaltrials.gov) - Aug 28, 2011
P4, N=30, Recruiting, Sponsor: Meir Medical Center
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Armonair Respiclick (fluticasone propionate MDPI) / Teva
Trial termination: Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients (clinicaltrials.gov) - Aug 25, 2011
P4, N=49, Terminated, Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting --> Recruiting Completed --> Terminated; Very poor enrollment
- |||| montelukast / Generic mfg., fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
Trial completion: The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial (The LOCCS Trial) (clinicaltrials.gov) - Aug 25, 2011
P4, N=495, Completed, Sponsor: American Lung Association Asthma Clinical Research Centers
Completed --> Terminated; Very poor enrollment Active, not recruiting --> Completed
- ||||| Iclusig (ponatinib) / Takeda, Otsuka, Incyte, Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
Clinical: Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Aug 25, 2011
P2, N=60, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
- ||| DNK-333 / Novartis
Enrollment change: Safety and Efficacy of DNK333 in Atopic Dermatitis Patients (clinicaltrials.gov) - Aug 23, 2011
P2, N=80, Completed, Sponsor: Novartis Pharmaceuticals
Active, not recruiting --> Completed N=60 --> 80
- |||| DNK-333 / Novartis
Trial completion: Safety and Efficacy of DNK333 in Atopic Dermatitis Patients (clinicaltrials.gov) - Aug 23, 2011
P2, N=80, Completed, Sponsor: Novartis Pharmaceuticals
N=60 --> 80 Recruiting --> Completed
- fluocinonide / Generic mfg.
New P2 trial: Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy (clinicaltrials.gov) - Aug 22, 2011
P2, N=31, Recruiting, Sponsor: OHSU Knight Cancer Institute
- | Bufomix Easyhaler (budesonide/formoterol dry powder inhaler) / Orion Corp
New P1 trial: Phase I Pharmacokinetic Study (BF-BLOCK) (clinicaltrials.gov) - Aug 22, 2011
P1, N=20, Completed, Sponsor: Orion Corporation, Orion Pharma
- ||||| felzartamab (MOR202) / HIBio
Combination therapy, Monotherapy: A Phase 1/2a Study of Human Anti-CD 38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma (clinicaltrials.gov) - Aug 18, 2011
P1/2, N=82, Recruiting, Sponsor: MorphoSys AG
- Zolinza (vorinostat) / Merck (MSD)
New P1 trial: Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies (clinicaltrials.gov) - Aug 18, 2011
P1, N=80, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
- | Calsed (amrubicin) / Sumitomo Pharma, BMS
Enrollment open, Combination therapy: Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma (clinicaltrials.gov) - Aug 18, 2011
P1/2, N=42, Recruiting, Sponsor: Michaela Liedtke
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||||||| mometasone furoate nasal spray / Generic mfg.
Trial completion: Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332) (clinicaltrials.gov) - Aug 18, 2011
P3, N=333, Completed, Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- bortezomib / Generic mfg., pegylated liposomal doxorubicin / Generic mfg.
Trial termination: Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma (clinicaltrials.gov) - Aug 17, 2011
P2, N=32, Terminated, Sponsor: Accelerated Community Oncology Research Network
Active, not recruiting --> Completed Completed --> Terminated; Study was closed to enrollment when it became clear that enrollment was too slow to complete full enrollment target within time frame allowed.
- pregabalin / Generic mfg.
Enrollment change, Surgery: The Effect of Pregabalin and Dexamethasone on Acute and Chronic Pain After Lumbar Spinal Surgery (clinicaltrials.gov) - Aug 17, 2011
P=N/A, N=108, Completed, Sponsor: Yonsei University
Completed --> Terminated; Study was closed to enrollment when it became clear that enrollment was too slow to complete full enrollment target within time frame allowed. N=90 --> 108
- methylprednisolone sodium succinate / Generic mfg.
Clinical: Systemic Effects of Epidural Methylprednisolone Injection on Glucose Tolerance in Diabetic Patients (clinicaltrials.gov) - Aug 17, 2011
P=N/A, N=25, Completed, Sponsor: Centre Hospitalier Universitaire Vaudois
- pregabalin / Generic mfg.
Trial completion, Surgery: The Effect of Pregabalin and Dexamethasone on Acute and Chronic Pain After Lumbar Spinal Surgery (clinicaltrials.gov) - Aug 17, 2011
P=N/A, N=108, Completed, Sponsor: Yonsei University
N=90 --> 108 Active, not recruiting --> Completed
- | fosdagrocorat (PF-04171327) / Pfizer
Trial completion: PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed Conditions (clinicaltrials.gov) - Aug 14, 2011
P1, N=27, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed Recruiting --> Completed
- |||| fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
Trial completion: ESWT: Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease (clinicaltrials.gov) - Aug 11, 2011
P4, N=255, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed Not yet recruiting --> Completed
- || Combivent (ipratropium/salbutamol) / Boehringer Ingelheim
Enrollment change: Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Aug 11, 2011
P=N/A, N=76130, Completed, Sponsor: GlaxoSmithKline
Not yet recruiting --> Completed N=43792 --> 76130
- ||||| Breo Ellipta (fluticasone furoate / vilanterol) / GSK, Innoviva
Enrollment change: Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Aug 11, 2011
P3, N=1226, Completed, Sponsor: GlaxoSmithKline
N=43792 --> 76130 N=1000 --> 1226
- ||||||| Breo Ellipta (fluticasone furoate / vilanterol) / GSK, Innoviva
Trial completion: Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Aug 11, 2011
P3, N=1226, Completed, Sponsor: GlaxoSmithKline
N=1000 --> 1226 Recruiting --> Completed
- ||||||| Breo Ellipta (fluticasone furoate / vilanterol) / GSK, Innoviva
Trial completion: A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Aug 11, 2011
P3, N=1031, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed Recruiting --> Completed
- Rituxan (rituximab) / Roche
Trial completion: Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma (clinicaltrials.gov) - Aug 11, 2011
P2, N=55, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Recruiting --> Completed Active, not recruiting --> Completed
- ||||| budesonide/formoterol / Generic mfg.
New P4 trial: SECURE2: Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients (clinicaltrials.gov) - Aug 10, 2011
P4, N=581, Completed, Sponsor: AstraZeneca
- Trial termination: Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2 (clinicaltrials.gov) - Aug 10, 2011
P3, N=5, Terminated, Sponsor: University of Arkansas
Active, not recruiting --> Completed Completed --> Terminated; low accrual
- ||| filanesib (ARRY-520) / Pfizer
Enrollment change: A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma (clinicaltrials.gov) - Aug 10, 2011
P1/2, N=80, Active, not recruiting, Sponsor: Array BioPharma
Completed --> Terminated; low accrual N=60 --> 80
- ||||| Ninlaro (ixazomib) / Takeda
New P2 trial: Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib (clinicaltrials.gov) - Aug 10, 2011
P2, N=103, Recruiting, Sponsor: Mayo Clinic
- ||| dexamethasone / Generic mfg., lenalidomide / Generic mfg.
Enrollment closed: A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression (clinicaltrials.gov) - Aug 10, 2011
P2, N=150, Active, not recruiting, Sponsor: Peter MacCallum Cancer Centre, Australia
N=60 --> 80 Recruiting --> Active, not recruiting
- | montelukast / Generic mfg., fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
New P4 trial: Management of Asthma in School-age Children on Therapy (clinicaltrials.gov) - Aug 9, 2011
P4, N=229, Completed, Sponsor: Professor Warren Lenney
- | dexamethasone / Generic mfg.
New P4 trial, Surgery: Dexamethasone for Pain After Shoulder Surgery (clinicaltrials.gov) - Aug 9, 2011
P4, N=97, Completed, Sponsor: University of Aarhus
- |||| Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi, Neupogen (filgrastim) / Kyowa Kirin, Amgen
Clinical: Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome (clinicaltrials.gov) - Aug 7, 2011
P2, N=53, Completed, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Rituxan (rituximab) / Roche
New P2 trial: S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma (clinicaltrials.gov) - Aug 7, 2011
P2, N=180, Recruiting, Sponsor: Southwest Oncology Group
- | cabazitaxel / Generic mfg.
New P2 trial: Study to assess the efficacy of budesonide in preventing diarrhea caused by treatment with cabazitaxel (CABARESC) (EUDRACT) - Aug 7, 2011
P2, N=250, Ongoing, Sponsor: Erasmus MC-Dani
- dexamethasone / Generic mfg., prednisone / Generic mfg.
Trial completion: Test Predicting Adrenal Insufficiency in Volunteers Under Prednisone Treatment (clinicaltrials.gov) - Aug 7, 2011
P4, N=39, Completed, Sponsor: University Hospital, Basel, Switzerland
Active, not recruiting --> Completed Recruiting --> Completed